טוען...
Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
It is of interest to evaluate the clinical effectiveness and safety of vildagliptin as monotherapy and combination therapy of vildagliptin and metformin for the management of type 2 diabetes mellitus (T2DM) patients in Indian settings. The study included patients with T2DM (aged >18 years) receiv...
שמור ב:
| הוצא לאור ב: | Bioinformation |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Biomedical Informatics
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8131578/ https://ncbi.nlm.nih.gov/pubmed/34092962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630017413 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|